Close

Oppenheimer Downgrades Celldex Therapeutics (CLDX) to Perform

March 7, 2016 9:38 AM EST Send to a Friend
Oppenheimer downgraded Celldex Therapeutics (NASDAQ: CLDX) from Outperform to Perform after the DSMB recommends discontinuation of Rindo.Analyst Christopher Marai commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login